Novomedix LLC
San Diego, CA Doing business as Novomedix LLC Novomedix, LLC
- UEI
- XQYMHKGDMU75
- CAGE
- 4C2X1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 7966 Arjons Dr Ste D, San Diego, CA 92126, USA
- Website
- novomedix.com
- Founded
- 2001
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel small molecule for the prevention and treatment of DMD cardiomyopathy - project summary duchenne muscular… | National Heart Lung and Blood Institute | $355,963 | |
| Arthrofibrosis control using small molecule inhibitors of interleukin-11 - abstract this program aims to develop and… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $314,362 | |
| Sbir phase II - enhanced overall survival in high-risk pediatric solid tumors using a novel oral small molecule | National Cancer Institute | $2,977,013 | |
| Novel oral small molecules for progressive pulmonary fibrosis - abstract the overall goal of this program is the… | National Heart Lung and Blood Institute | $306,872 | |
| Definitive (GLP) toxicity and toxicology studies for a novel small molecule for protection against cardiotoxicity in… | National Heart Lung and Blood Institute | $1,000,000 |
About Novomedix LLC
Novomedix LLC is a woman-owned small business based in San Diego, California, specializing in developing novel small molecule therapeutics for complex medical conditions. Registered in SAM.gov with a unique entity identifier XQYMHKGDMU75, the company focuses on innovative pharmaceutical research and development across multiple therapeutic areas, with a particular emphasis on oncology, cardiovascular disease, and fibrotic disorders. The company operates as a partnership or limited liability partnership, leveraging its scientific expertise to create targeted treatments for challenging medical conditions.
Through its federal contract awards, Novomedix LLC has primarily engaged in Small Business Innovation Research (SBIR) contracts with the National Cancer Institute (NCI). The company's federal contract work has been specifically focused on pediatric oncology research, notably developing a novel oral small molecule to enhance overall survival in high-risk pediatric solid tumors. The most significant contract is a $2,977,013 firm fixed-price SBIR Phase II award, which builds upon a previous $355,000 Phase I concept award for research on rhabdomyosarcoma treatment. These contracts are designated as Total Small Business set-asides, highlighting the company's commitment to innovative research in challenging medical domains.
Novomedix LLC has secured multiple federal grant awards from agencies like the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). These grants support research in diverse areas including pulmonary fibrosis, cardiovascular disease protection, arthrofibrosis treatment, and cardiotoxicity mitigation for cancer patients. Specific grant projects include developing small molecule therapeutics to protect against doxorubicin-induced cardiotoxicity in triple-negative breast cancer, creating treatments for diabetic cardiovascular disease, investigating therapies for arthrofibrosis, and exploring novel approaches to progressive pulmonary fibrosis. The grant awards range from $306,872 to $1,000,000, demonstrating the company's broad scientific capabilities and commitment to addressing complex medical challenges through innovative pharmaceutical research.
Quick answers
What is Novomedix LLC's UEI?
Novomedix LLC's Unique Entity ID (UEI) in SAM.gov is XQYMHKGDMU75.
What is Novomedix LLC's CAGE code?
Novomedix LLC's CAGE code is 4C2X1.
What is Novomedix LLC's primary NAICS code?
Novomedix LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Novomedix LLC located?
Novomedix LLC's physical address in SAM.gov is 7966 Arjons Dr Ste D, San Diego, CA 92126, USA.
Is Novomedix LLC registered in SAM.gov?
Yes. Novomedix LLC's SAM.gov registration is active through May 7, 2027.
What is Novomedix LLC's most recent federal award?
Novomedix LLC's most recent federal grant award is Novel small molecule for the prevention and treatment of DMD cardiomyopathy - project summary duchenne muscular… (R43HL182659), from National Heart Lung and Blood Institute, on September 1, 2026.
On GovTribe
See Novomedix LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors